Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SSE
2196
Stock
Yield per half year: 0%
Dividend yield: 2.34%
Sector: Healthcare

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

554433221100

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
9/10
11.19 118.32 -90.54% 0 0%
P/S 1.08 16.05 -93.27%
P/BV 1.07 5.73 -81.32%
P/FCF 0 28.9 -100%
Ev/Ebitda 15.48 16.62 -6.88%
Ev/S 2.13 17.13 -87.55%
Ev/FCF 0 26.49 -100%
E/P 0.054 0.0239 125.75%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
13.28 -47.67 -127.85% 13.28 0%
ROE 8.61 2.65 225.08%
ROA 2.25 3.24 -30.49%
ROIC 0 0 0%
ROS 9.59 -59.32 -116.17%
ROCE 0 1.66 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
5.22 0.5881 787.16% 5.22 0%
Nеt Debt/Ebitda 0 -0.1844 -100%
Debt/Ratio 0 0.1106 -100%
Debt/Equity 0 0.9261 -100%
Debt/Net Income 7.23 5.27 37%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.85/10
2.34 0.3202 630.9% 0 0%
Number of years of dividend growth 0 1.05 -100%
DSI 1 0.6806 46.94%
Average dividend growth 0 -1.23 -100%
Average percentage for 5 years 0 1.28 -100%
Average percentage for payments 0 87.72 -100%
Difference from average difference in sector 2.02

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
3/10
0 26.24 -100%
Growth impulse Ebitda in 5 years 0 12.85 -100%
Growth impulse Net Income in 5 years 0 309.26 -100%
Growth impulse FCF in 5 years 0 45.01 -100%
Growth impulse EPS in 5 years 0 18.38 -100%
IP Score
4.73/10

Similar companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd

Jiangsu Hengrui Medicine Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription